SPP1 |
P10451
|
secreted phosphoprotein 1
|
|
2.1E-06 |
0.353 |
0.885 |
NFE2L2 |
Q16236
|
nuclear factor, erythroid 2 like 2
|
Enzyme
|
3.6E-03 |
0.357 |
0.885 |
MYC |
P01106
|
MYC proto-oncogene, bHLH transcription factor
|
Transcription factor
|
1.00 |
0.344 |
0.923 |
CASP3 |
P42574
|
caspase 3
|
Enzyme
|
0.10 |
0.351 |
0.923 |
FGFR1 |
P11362
|
fibroblast growth factor receptor 1
|
Kinase
|
1.00 |
0.362 |
0.885 |
NLRP3 |
Q96P20
|
NLR family pyrin domain containing 3
|
|
8.1E-04 |
0.361 |
0.962 |
CAT |
P04040
|
catalase
|
Enzyme
|
1.6E-10 |
0.359 |
0.962 |
EGF |
P01133
|
epidermal growth factor
|
|
8.5E-17 |
0.357 |
0.923 |
H3P10 |
|
H3 histone pseudogene 10
|
|
|
0.350 |
0.846 |
FAS |
P25445
|
Fas cell surface death receptor
|
|
0.81 |
0.372 |
0.923 |
IL18 |
Q14116
|
interleukin 18
|
|
3.1E-02 |
0.365 |
0.923 |
BRCA1 |
P38398
|
BRCA1 DNA repair associated
|
Enzyme
|
9.2E-29 |
0.367 |
0.923 |
CXCR4 |
P61073
|
C-X-C motif chemokine receptor 4
|
G-protein coupled receptor
|
1.8E-02 |
0.362 |
0.923 |
ICAM1 |
P05362
|
intercellular adhesion molecule 1
|
|
3.5E-02 |
0.364 |
0.962 |
MIR21 |
|
microRNA 21
|
|
|
0.363 |
0.846 |
FN1 |
P02751
|
fibronectin 1
|
Signaling
|
1.4E-03 |
0.365 |
0.962 |
HMGB1 |
P09429
|
high mobility group box 1
|
Nucleic acid binding
|
0.82 |
0.368 |
0.923 |
CTLA4 |
P16410
|
cytotoxic T-lymphocyte associated protein 4
|
|
0.94 |
0.369 |
0.923 |
REN |
P00797
|
renin
|
Enzyme
|
2.4E-07 |
0.370 |
0.923 |
KIT |
P10721
|
KIT proto-oncogene, receptor tyrosine kinase
|
Kinase
|
0.98 |
0.366 |
0.808 |
CD44 |
P16070
|
CD44 molecule (Indian blood group)
|
|
2.4E-07 |
0.363 |
0.962 |
HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
TERT |
O14746
|
telomerase reverse transcriptase
|
Enzyme
|
0.99 |
0.374 |
0.846 |
PTPN11 |
Q06124
|
protein tyrosine phosphatase non-receptor type 11
|
|
1.00 |
0.385 |
0.923 |
MDM2 |
Q00987
|
MDM2 proto-oncogene
|
Nucleic acid binding
|
1.00 |
0.362 |
0.846 |